S |
2020-04-08 13:54:57.0 |
Spring Bank Pharmaceuticals |
SBPH |
UBS Oncology Impact Fund L |
3.5% |
view |
S |
2020-02-12 16:37:48.0 |
Spring Bank Pharmaceuticals |
SBPH |
ADAGE CAPITAL PARTNERS GP |
0.0% |
view |
B |
2018-10-18 14:28:20.0 |
Spring Bank Pharmaceuticals |
SBPH |
ADAGE CAPITAL PARTNERS GP |
6.18% |
view |
S |
2018-02-12 16:02:02.0 |
Spring Bank Pharmaceuticals |
SBPH |
Iyer Radhakrishnan P |
3.9% |
view |
S |
2018-02-12 16:00:38.0 |
Spring Bank Pharmaceuticals |
SBPH |
Eichler Kurt M |
5.6% |
view |
B |
2018-02-06 16:08:21.0 |
Spring Bank Pharmaceuticals |
SBPH |
UBS Oncology Impact Fund L |
10.6% |
view |
B |
2017-02-10 16:17:57.0 |
Spring Bank Pharmaceuticals |
SBPH |
Eichler Kurt M |
6.1% |
view |
B |
2017-02-10 16:16:03.0 |
Spring Bank Pharmaceuticals |
SBPH |
Iyer Radhakrishnan P |
5.2% |
view |
B |
2016-12-05 16:51:02.0 |
Spring Bank Pharmaceuticals |
SBPH |
UBS Oncology Impact Fund L |
6.4% |
view |
B |
2016-12-05 07:33:55.0 |
Spring Bank Pharmaceuticals |
SBPH |
Peter Lacaillade |
n/a |
view |
B |
2016-09-16 17:47:02.0 |
Spring Bank Pharmaceuticals |
SBPH |
Peter Lacaillade |
n/a |
view |